Skip navigation
Browsing by Author Friedlander, M.
Showing results 1 to 3 of 3
| Preview | Issue Date | Title / Name | Author(s) |
| Aug-2016 | The effect of pulmonary function testing on bleomycin dosing in germ cell tumours | Roncolato, F. T.; Chatfield, M.; Houghton, B.; Toner, G.; Stockler, M.; Thomson, D.; Friedlander, M.; Gurney, H.; Rosenthal, M.; Grimison, P.; Houghton, Baerin | |
| Sep-2023 | Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial | Friedlander, M.; Mileshkin, L.; Lombard, J.; Frentzas, S.; Gao, B.; Wilson, M.; Meniawy, T.; Baron-Hay, S.; Briscoe, K.; McCarthy, N.; Fountzilas, C.; Cervantes, A.; Ge, R.; Wu, J.; Spira, A.; Briscoe, Karen | |
| Jul-2020 | Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors | Desai, J.; Gan, H.; Barrow, C.; Jameson, M.; Atkinson, V.; Haydon, A.; Millward, M.; Begbie, S.; Brown, M.; Markman, B.; Patterson, W.; Hill, A.; Horvath, L.; Nagrial, A.; Richardson, G.; Jackson, C.; Friedlander, M.; Parente, P,; Tran, B.; Wang, L.; Chen, Y.; Tang, Z.; Huang, W.; Wu, J.; Zeng, D.; Luo, L.; Solomon, B.; Begbie, Stephen | |
